MDxHealth SA
(NASDAQ: MDXH)
|
9:00 PM UTC, 11/21/24 | |||
---|---|---|---|---|
Last: $1.71 | Change: +0.09 | %Change: +5.56% | Volume: 356,375 |
Open: | $ 1.62 | Volume: | 356,375 | |
---|---|---|---|---|
High: | $ 1.73 | Yield(%) | 0.00 | |
Low: | $ 1.61 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 44.21M | |
EPS ($) | -1.53 | Shares Out: | 27.29M |
% Price Change (last 4 weeks): | -19.00 |
---|---|
% Price Change (last 13 weeks): | -50.46 |
% Price Change (last 26 weeks): | -41.52 |
% Price Change (last 52 weeks): | -35.20 |
% Price Change (year to date): | -58.88 |
Return on Equity (%): | -521.70 |
---|---|
Return on Assets (%): | -34.72 |
Return on Invested Capital (%): | -95.78 |
Gross Profit Margin (%): | 56.18 |
---|---|
Net Profit Margin (%): | -61.40 |
Operating Profit Margin (%): | -38.27 |
50-day Moving Average: | $2.10 |
---|---|
200-day Moving Average: | $2.65 |
Avg. Daily Vol. (last 50 days): | 139,724 |
Avg. Daily Vol. (last 200 days): | 70,567 |
52-wk high: | $4.64 |
52-wk low: | $1.55 |
Bid: | $1.63 |
Ask: | $1.78 |
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
|
MDxHealth SA
CAP Business Center Zone Industrielle des Hauts-Sarts Herstal WA 4040 Phone: 32.4.257.70.21 Fax: 32.4.364.20.71 http://www.mdxhealth.com |
Earnings (1year) ($): | -1.53 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.26 |
Cash Flow ($): | -1.33 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 1.45 |
Price/Book (x): | 14.92 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 1.81 |
---|---|
Current Ratio (x): | 1.95 |
LT Debt/Equity (x): | 543.04 |
Total Debt/Equity (x): | 572.49 |